Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 117.39B | 115.77B | 111.97B | 114.20B | 107.61B | 101.00B |
Gross Profit | 39.80B | 28.68B | 25.21B | 18.88B | 16.43B | 15.35B |
EBITDA | 52.56B | 50.38B | 44.52B | 43.08B | 38.95B | 38.21B |
Net Income | 12.07B | 11.21B | 17.79B | 8.00B | 4.18B | 4.16B |
Balance Sheet | ||||||
Total Assets | 304.98B | 304.93B | 313.44B | 298.59B | 281.63B | 264.92B |
Cash, Cash Equivalents and Short-Term Investments | 21.65B | 8.37B | 7.24B | 5.62B | 6.01B | 12.94B |
Total Debt | 148.55B | 145.15B | 138.75B | 147.75B | 142.07B | 137.26B |
Total Liabilities | 207.20B | 206.29B | 222.21B | 211.27B | 200.16B | 192.37B |
Stockholders Equity | 64.08B | 63.30B | 56.92B | 48.56B | 42.68B | 35.92B |
Cash Flow | ||||||
Free Cash Flow | 22.50B | 20.70B | 19.43B | 11.71B | 5.81B | 5.05B |
Operating Cash Flow | 41.43B | 39.87B | 37.30B | 35.82B | 32.17B | 23.74B |
Investing Cash Flow | -20.72B | -18.90B | -22.91B | -22.31B | -27.40B | -22.65B |
Financing Cash Flow | -14.53B | -20.28B | -12.83B | -15.44B | -10.78B | 7.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | €159.20B | 12.42 | 19.60% | 2.81% | 4.90% | 176.57% | |
71 Outperform | €3.28B | 18.38 | 2.93% | 0.27% | -1.02% | -41.62% | |
68 Neutral | €5.36B | 11.66 | 7.78% | 6.16% | 0.32% | -1.50% | |
66 Neutral | €4.76B | ― | -1.07% | 7.45% | 2.37% | -123.95% | |
62 Neutral | $42.18B | -1.51 | -12.07% | 2.79% | 2.09% | -71.01% | |
61 Neutral | €3.36B | 13.74 | 18.97% | 6.97% | -7.04% | 18.59% |